From the end of 2022 through Nov. 19, the benchmark S&P 500 index rose a stunning 54.1%. As is often the case during bull ...

Johnson & Johnson is a slow, steady Dividend King at the right price for buyers today. Political uncertainty has created ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson & Johnson (NYSE:JNJ) is about to trade ex-dividend in the next 3 days. The ex-dividend ...

Under Sanofi's new plan, certain hospitals covered by the 340B program would order drugs at full price from a wholesaler, the ...

ABBV stock has seen strong gains of 85% from levels of $90 in early January 2021 to around $165 now, vs. an increase of about ...

Leerink Partners analyst David Risinger has maintained their bullish stance on JNJ stock, giving a Buy rating on November 14.Don't Miss our ...

BAM and SHOP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2024. A few of its recent ...

J&J JNJ stock has plunged 6.1% in a month, losing almost $24 billion of its market value. Though slowing sales in its MedTech ...

Lawyers claim Johnson & Johnson (J&J) “knew for decades” that there was allegedly asbestos present in its talc products, ...

Johnson & Johnson and Merck & Co. are cutting jobs in China, as they face growing competition from domestic rivals resulting ...

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated ...